Shipp MA - Search Results

1

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.

Roemer MG, Advani RH, Ligon AH, Natkunam Y, Redd RA, Homer H, Connelly CF, Sun HH, Daadi SE, Freeman GJ, Armand P, Chapuy B, de Jong D, Hoppe RT, Neuberg DS, Rodig SJ, Shipp MA. Roemer MG, et al. Among authors: shipp ma. J Clin Oncol. 2016 Aug 10;34(23):2690-7. doi: 10.1200/JCO.2016.66.4482. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069084 Free PMC article.

2

Prognostic factors in non-Hodgkin's lymphoma.

Shipp M. Shipp M. Curr Opin Oncol. 1992 Oct;4(5):856-62. doi: 10.1097/00001622-199210000-00007. Curr Opin Oncol. 1992. PMID: 1457500 Review.

3

The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.

Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS, Rosenthal DS, Skarin AT, Canellos GP. Shipp MA, et al. J Clin Oncol. 1990 Jan;8(1):84-93. doi: 10.1200/JCO.1990.8.1.84. J Clin Oncol. 1990. PMID: 1688615 Clinical Trial.

4

Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.

Weeks JC, Yeap BY, Canellos GP, Shipp MA. Weeks JC, et al. Among authors: shipp ma. J Clin Oncol. 1991 Jul;9(7):1196-203. doi: 10.1200/JCO.1991.9.7.1196. J Clin Oncol. 1991. PMID: 1710656

5

Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy.

Shipp MA, Klatt MM, Yeap B, Jochelson MS, Mauch PM, Rosenthal DS, Skarin AT, Canellos GP. Shipp MA, et al. J Clin Oncol. 1989 May;7(5):613-8. doi: 10.1200/JCO.1989.7.5.613. J Clin Oncol. 1989. PMID: 2468746

6

Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.

Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, Tung N, Wheeler C, Beard CJ, Canellos GP, et al. Kirn D, et al. Among authors: shipp ma. J Clin Oncol. 1993 Jul;11(7):1336-43. doi: 10.1200/JCO.1993.11.7.1336. J Clin Oncol. 1993. PMID: 8315431

7

High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.

Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LN. Shipp MA, et al. J Clin Oncol. 1995 Dec;13(12):2916-23. doi: 10.1200/JCO.1995.13.12.2916. J Clin Oncol. 1995. PMID: 8523055

8

Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.

Janicek M, Kaplan W, Neuberg D, Canellos GP, Shulman LN, Shipp MA. Janicek M, et al. Among authors: shipp ma. J Clin Oncol. 1997 Apr;15(4):1631-7. doi: 10.1200/JCO.1997.15.4.1631. J Clin Oncol. 1997. PMID: 9193363

9

A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.

Yakushijin Y, Steckel J, Kharbanda S, Hasserjian R, Neuberg D, Jiang W, Anderson I, Shipp MA. Yakushijin Y, et al. Among authors: shipp ma. Blood. 1998 Jun 1;91(11):4282-91. Blood. 1998. PMID: 9596677 Free article.

10

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.

Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, Radford JA, Salles G, Schmitz N, Symann M, Armitage JO, Coiffier B, Philip T. Shipp MA, et al. Ann Oncol. 1999 Jan;10(1):13-9. doi: 10.1023/a:1008397220178. Ann Oncol. 1999. PMID: 10076716 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page